The ReadoutSEC charges former uBiome execs, the power of drug names, & a biotech bestseller By Meghana Keshavan March 19, 2021 Reprints Alex Hogan/STAT The Readout for March 19, 2021 About the Author Reprints Meghana Keshavan Biotech Correspondent Meghana Keshavan covers biotech and contributes to The Readout newsletter. [email protected] @megkesh
The Readout Meghana Keshavan Regeneron targets obesity, a new microbiome deal, & comparing cancer drug costs
The Readout Damian Garde Should the feds investigate Aduhelm? Plus: biotech’s biggest binaries & regenerating heart tissue
Exclusive Rachel Cohrs STAT Plus: With Fat Joe concerts and Super Bowl ads, a cadre of billionaires is mounting an unorthodox campaign against hospitals
Matt's Take Matthew Herper STAT Plus: Battle for the soul of Illumina is also a referendum on its CEO
Health Isabella Cueto and Olivia Goldhill STAT Plus: Ketamine clinics’ bust serves as warning of business challenge facing psychedelic therapy